Navigation Links
CME LLC Announces the Launch of the CME Activity Advances in the Management of Major Depressive Disorders

JERSEY CITY, N.J., Jan. 18, 2012 /PRNewswire/ -- CME LLC has officially launched an online educational activity titled "Advances in the Management of Major Depressive Disorders" on Developed for psychiatrists, primary care physicians, nurses, and other health care professionals, this Case Challenge activity is intended to provide possible treatment options and individualized management approaches, including the augmentation of antidepressant therapy with folate formulations, for consideration when treating patients with major depressive disorder (MDD) in order to provide optimal patient outcomes. This activity is supported by an educational grant from Pamlab, L.L.C.

C. Brendan Montano, MD, the Director of Research at Connecticut Clinical Research, in Cromwell, Connecticut and Richard C. Shelton, MD, a James G. Blakemore Professor in the Department of Psychiatry, Professor in Departments of Psychology and Pharmacology, and Vice-Chair of Clinical Research at Vanderbilt University School of Medicine in Nashville, Tennessee comprise the faculty for the activity.

Cased-based methods of learning are extremely effective in getting across educational messages and demonstrating practical strategies. In this Case Challenge activity, participants are encouraged to determine treatment strategies based on case histories and patient presentations. "Non-response to antidepressant therapy, as defined by the presence or absence of full recovery of depression, is the rule rather than the exception for the treatment of depression, even in the primary care setting. This CME activity presents real-world examples of the management of depression to full remission. As such, I think it will provide practitioners practical strategies for managing depression to wellness." – Richard C. Shelton

Upon completion of the activity, participants should be able to:

  • Utilize evidence-based strategies to best sequence administration of antidepressant therapy with adjunctive therapies to enhance response rates and achieve remission
  • Compare and contrast the long-term efficacy, safety, and tolerability of adjunctive therapies indicated for depression to better individualize therapy
  • Understand the relationship between folate and depression, including the contribution of folate to monoamine deficiencies, to determine patient type
  • Review currently available sources of folate supplementation and their potential role in MDD management

The online activity is CME-certified and approved for nursing contact hours.  It will be available through October 31, 2012. 


CME LLC develops educational plans designed to meet the needs of practicing clinicians based on demonstrated gaps within a target audience. Individual activities focus on maintaining, developing, or increasing the knowledge, skills, competence, and professional performance of clinicians to improve patient care. Founded in 1978 with the vision to provide high-quality, practical medical education and information for mental health clinicians, CME LLC's reach now expands to educational offerings for primary care, oncology, and practice management professionals in various formats including live events, print formats, interactive online activities and more.

Continuing Education Credit

CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME LLC designates this enduring activity for a 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider Number CEP12748 for 1 contact hour.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion, as AAPA, AANP and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Contact: Michael DeMilt
201.984.6224 phone
201.336.6497 fax

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
(Date:12/1/2015)... och UPPSALA, Sverige, December 1, 2015 ... International Breast Cancer Study Group (IBCSG, ... Bryssel) att ingå i en klinisk studie av ... --> --> Studien, med namn ... behandlas med anti-hormonella läkemedel i kombination med palbociclib, ...
(Date:11/30/2015)... Minn. and BASEL, Switzerland ... Laboratories, Inc. (Upsher-Smith), through its wholly-owned UK subsidiary ... further development of a novel, oral small molecule inhibitor ... that may be effective in the treatment of inflammatory ... clinical development. --> --> ...
(Date:11/30/2015)... 1, 2015 Express Scripts (NASDAQ: ESRX ) ... IMMY ) to drive access to a low-cost alternative to ... toxoplasmosis that has been recently priced out of reach for ... systems. --> --> Imprimis ... (a form of folic acid) for $1 per capsule for people ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Third Molar SEO ... it has officially launched a sleek, mobile-ready and user-centric redesigned website. , Vivek ... website clearly outlines the benefits that its SEO services provide to dentists and ...
(Date:11/30/2015)... ... 2015 , ... Trevor and Taylor Crabb have unveiled an exciting new ... represent the United States. This hybrid crowdfunding campaign is designed to provide ... in addition to offering corporate sponsors with some great marketing deliverables with the brothers ...
(Date:11/30/2015)... , ... December 01, 2015 , ... ... Christina Colon as a 2015-2016 inductee into its VIP Woman of the ... NAPW is the nation’s leading networking organization exclusively for professional women, boasting 850,000 ...
(Date:11/30/2015)... ... December 01, 2015 , ... The National Association ... inductee into its VIP Woman of the Year Circle. She is recognized with ... organization exclusively for professional women, boasting 850,000 members and over 200 operating Local ...
(Date:11/30/2015)... ... December 01, 2015 , ... Live Very Well is ... insurance plans on . The multi-carrier insurance exchange platform offers individual ... allowing consumers to compare, quote and match plans to meet their needs. ...
Breaking Medicine News(10 mins):